Viral Clearance Market Forecasted to Reach USD $2.06 Billion by 2030 at 16.4% CAGR

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.

What Is the Projected Growth Rate of the Viral Clearance Market Through 2030?
The viral clearance market size has grown rapidly in recent years. It will grow from $0.96 billion in 2025 to $1.12 billion in 2026 at a compound annual growth rate (CAGR) of 16.7%. The growth in the historic period can be attributed to limited viral clearance technologies, increasing viral contamination concerns in biologics, reliance on conventional filtration methods, growing regulatory scrutiny, expansion of pharmaceutical and biotech manufacturing pipelines.

The viral clearance market size is expected to see rapid growth in the next few years. It will grow to $2.06 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to development of next-generation viral inactivation methods, rising adoption of nanofiltration and membrane chromatography, increasing biologics and gene therapy production, integration of automation in viral clearance workflows, growing investment in viral detection assay development. Major trends in the forecast period include increasing adoption of advanced viral detection and inactivation methods, rising demand for safe and virus-free vaccines and therapeutics, expansion of cellular and gene therapy products requiring viral clearance, integration of high-efficiency filtration and nanofiltration technologies, growing outsourcing to contract research organizations for viral clearance services.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/report/viral-clearance-global-market-report

What Are the Key Market Drivers and Opportunities in the Viral Clearance Market?
The rising prevalence of chronic diseases is expected to propel the growth of the viral clearance market going forward. Chronic diseases are ongoing medical conditions that develop over time and last for months or years, often requiring continuous care or management. The prevalence of chronic diseases is increasing globally, primarily driven by aging populations, as people live longer due to improvements in healthcare and living standards, leading to a rise in age-related conditions such as cardiovascular diseases, diabetes, arthritis, and cancer. Viral clearance is crucial in developing biologics and gene therapies used to treat chronic diseases, ensuring their safety and effectiveness. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising prevalence of chronic diseases is driving the growth of the viral clearance market.

What Are the Key Segment Classifications in the Viral Clearance Market?
The viral clearance market covered in this report is segmented –

1) By Method: Viral Clearance Method, Viral Removal Method, Viral Inactivation Method, Viral Detection Method
2) By Application: Vaccines And Therapeutics, Blood And Blood Products, Cellular And Gene Therapy Products, Tissue And Tissue Products, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Other End Users

Subsegments:
1) By Viral Clearance Method: Downstream Processing, Filtration, Chromatography, Precipitation, Nanofiltration
2) By Viral Removal Method: Membrane Chromatography, Depth Filtration, Nanofiltration, Ultrafiltration, Protein A Affinity Chromatography
3) By Viral Inactivation Method: Solvent Detergent Method, Low pH Treatment, Heat Treatment (Pasteurization), UV-C Irradiation, Caprylate Treatment
4) By Viral Detection Method: PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), Nucleic Acid Testing (NAT), Cell-Based Assays, Transmission Electron Microscopy (TEM)

Which Trends Are Positively Affecting the Viral Clearance Market Expansion?
Major companies operating in the viral clearance market are focusing on developing innovative products such as next-generation virus removal filters to enhance viral safety and improve biopharmaceutical manufacturing efficiency. Next-generation virus removal filters are advanced filtration devices designed to efficiently remove viruses from biopharmaceutical products, helping to ensure product safety, increase filtration speed, and support higher productivity in drug manufacturing. For instance, in October 2024, Asahi Kasei Medical Co., Ltd., a Japan-based medical and bioprocess solutions company, launched its next-generation Planova FG1 virus-removal filter, which offers roughly seven-times higher flux than Planova BioEX to shorten filtration times, reduce virus-breakthrough risk, and maintain strong protein and virus-removal performance without a prefilter; the FG1 is compatible with standard CIP/SIP processes and entered mass production in smaller sizes, with larger formats planned to support scale-up and enable higher throughput and faster cycle times for biomanufacturers.

Who Are the Emerging Players in the Viral Clearance Market?
Major companies operating in the viral clearance market are Merck Group, Thermo Fisher Scientific Inc., Asahi Kasei Corporation, SGS SA, Eurofins Scientific Inc., Lonza Group AG, WuXi AppTec, Catalent Biologics, Charles River Laboratories, Nelson Labs, Pall Corporation, Sartorius AG, Creative Biolabs, Texcell SA, Vironova AB.

Get the full viral clearance market report here:
https://www.thebusinessresearchcompany.com/report/viral-clearance-global-market-report

Which regions are expected to experience the fastest growth in the Viral Clearance Market?
North America was the largest region in the viral clearance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral clearance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: Global Market Research Reports & Consulting | The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company